Literature DB >> 33690171

Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma.

Qiangnu Zhang1,2, Lijun Qiao1,2, Quan Liu1,2, Xiangpan Kong3, Jun Hu4, Weibin Hu1,5, Zongze Wu1,5, Mingyue Li1,5, Liping Liu1,5.   

Abstract

The present study was designed to update the knowledge about hypoxia-related multi-omic molecular landscape in hepatocellular carcinoma (HCC) tissues. Large-size HCC datasets from multiple centers were collected. The hypoxia exposure of tumor tissue from patients in 10 HCC cohorts was estimated using a novel HCC-specific hypoxia score system constructed in our previous study. A comprehensive bioinformatical analysis was conducted to compare hypoxia-associated multi-omic molecular features in patients with a high hypoxia score to a low hypoxia score. We found that patients with different exposure to hypoxia differed significantly in transcriptomic, genomic, epigenomic, and proteomic alterations, including differences in mRNA, microRNA (miR), and long non-coding RNA (lncRNA) expression, differences in copy number alterations (CNAs), differences in DNA methylation levels, differences in RNA alternative splicing events, and differences in protein levels. HCC survival- associated molecular events were identified. The potential correlation between molecular features related to hypoxia has also been explored, and various networks have been constructed. We revealed a particularly comprehensive hypoxia-related molecular landscape in tumor tissues that provided novel evidence and perspectives to explain the role of hypoxia in HCC. Clinically, the data obtained from the present study may enable the development of individualized treatment or management strategies for HCC patients with different levels of hypoxia exposure.

Entities:  

Keywords:  hepatocellular carcinoma; hypoxia; microenvironment; multi-omics; non-coding RNA

Mesh:

Substances:

Year:  2021        PMID: 33690171      PMCID: PMC7993683          DOI: 10.18632/aging.202723

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  28 in total

1.  Chromosomal instability in HCC: a key function for checkpoint kinase 2.

Authors:  Robert Eferl; Michael Trauner
Journal:  Gut       Date:  2017-05-05       Impact factor: 23.059

2.  Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.

Authors:  Hye-Young Nam; Darshan S Chandrashekar; Anirban Kundu; Sandeep Shelar; Eun-Young Kho; Guru Sonpavde; Gurudatta Naik; Pooja Ghatalia; Carolina B Livi; Sooryanarayana Varambally; Sunil Sudarshan
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

Review 3.  Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia.

Authors:  Ashlyn G Rickard; Gregory M Palmer; Mark W Dewhirst
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro.

Authors:  Brita Singers Sørensen; Kasper Toustrup; Michael R Horsman; Jens Overgaard; Jan Alsner
Journal:  Acta Oncol       Date:  2010-10       Impact factor: 4.089

Review 5.  Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments.

Authors:  Mario Petrillo; Francesca Patella; Filippo Pesapane; Matteo B Suter; Anna M Ierardi; Salvatore A Angileri; Chiara Floridi; Massimo de Filippo; Gianpaolo Carrafiello
Journal:  Future Oncol       Date:  2018-05-01       Impact factor: 3.404

6.  A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.

Authors:  Amanda Eustace; Navin Mani; Paul N Span; Joely J Irlam; Janet Taylor; Guy N J Betts; Helen Denley; Crispin J Miller; Jarrod J Homer; Ana M Rojas; Peter J Hoskin; Francesca M Buffa; Adrian L Harris; Johannes H A M Kaanders; Catharine M L West
Journal:  Clin Cancer Res       Date:  2013-07-02       Impact factor: 12.531

Review 7.  The role of hypoxia-induced miR-210 in cancer progression.

Authors:  Kyvan Dang; Kenneth A Myers
Journal:  Int J Mol Sci       Date:  2015-03-19       Impact factor: 5.923

Review 8.  Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors.

Authors:  Carolina Méndez-Blanco; Flavia Fondevila; Andrés García-Palomo; Javier González-Gallego; José L Mauriz
Journal:  Exp Mol Med       Date:  2018-10-12       Impact factor: 8.718

9.  miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer.

Authors:  Fei Xu; Jing-Jun Yan; Yun Gan; Ying Chang; Hong-Ling Wang; Xing-Xing He; Qiu Zhao
Journal:  Mol Ther Nucleic Acids       Date:  2019-09-12       Impact factor: 8.886

10.  Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.

Authors:  F M Buffa; A L Harris; C M West; C J Miller
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.